Skip to main content
A

ATOMO DIAGNOSTICS LIMITED — Investor Relations & Filings

Ticker · AT1 ISIN · AU0000080327 ASX Manufacturing
Open in API
Filings indexed 389 across all filing types
Latest filing 2026-04-22 Report Publication Anno…
Country AU Australia
Listing ASX AT1

About ATOMO DIAGNOSTICS LIMITED

https://www.atomodiagnostics.com/

Atomo Diagnostics Limited specializes in the design and manufacture of integrated rapid diagnostic test (RDT) platforms. The company focuses on improving the usability and reliability of point-of-care testing through its proprietary AtomoRapid technology. This platform integrates essential components, such as a safety lancet and a calibrated blood collection system, into a single, user-friendly device. Key applications include HIV screening, COVID-19 detection, and pregnancy testing. By simplifying the testing procedure and reducing the risk of user error, the company provides solutions for both professional clinical environments and consumer self-testing markets. Its products are designed to deliver laboratory-grade accuracy in decentralized settings, supporting global health initiatives and individual health management.

Recent filings

Filing Released Lang Actions
Investor Webinar Presentation 1 page 202.0KB
Report Publication Announcement Classification · 1% confidence The document is an ASX announcement notifying investors about the upcoming release date for the company’s Q3 FY26 results and a supporting webinar presentation. It does not contain the full report or presentation materials; instead, it announces the timing of the release and how to register for the webinar. This matches the definition of a Report Publication Announcement (RPA).
2026-04-22 English
Response to ASX Aware Letter 11 pages 798.8KB
Regulatory Filings Classification · 1% confidence The document is a detailed response letter to ASX Compliance concerning Listing Rule inquiries and trading halt disclosures. It is not an operational report (e.g., earnings, annual report), nor a shareholder meeting package, nor a direct financial announcement. It is a regulatory correspondence addressing ASX queries, which falls under the general regulatory filings category. Therefore, it should be classified as a Regulatory Filing (RNS).
2026-04-16 English
Cancel - Proposed issue of securities - AT1 8 pages 26.5KB
Share Issue/Capital Change Classification · 1% confidence The document is an ASX Appendix 3B announcement detailing a proposed issue of securities under a share purchase plan (including cancellation of the prior Appendix 3B). It provides the number and class of securities, issue price, timetable, scale-back arrangements, attaching options, and ASX Listing Rule references. This is not a full financial report but rather a share issuance/capital change announcement. Therefore, it falls under Share Issue/Capital Change (Code: SHA).
2026-04-16 English
Update - Proposed issue of securities - AT1 12 pages 38.3KB
Share Issue/Capital Change Classification · 1% confidence The document is an ASX Appendix 3B announcement detailing a proposed issue of securities under a share purchase plan and placement (new ordinary shares and attaching options). It is a formal announcement of a new share issue, mapping directly to the “Share Issue/Capital Change” category.
2026-04-16 English
Share Purchase Plan Prospectus 52 pages 873.9KB
Capital/Financing Update Classification · 1% confidence The document is a formal SPP (Security Purchase Plan) Prospectus detailing an offer of new shares and attached options to raise up to $1,000,000. It is a capital‐raising transaction disclosure rather than an annual report, management change notice, or earnings release. The closest category is 'Capital/Financing Update' (CAP) because it describes a fundraising activity and changes to the capital structure through new share issues.
2026-04-15 English
Proposed issue of securities - AT1 8 pages 26.8KB
Share Issue/Capital Change Classification · 1% confidence The document is an Appendix 3B announcement under ASX Listing Rules, detailing the proposed issue of securities (ordinary shares and options) under a securities purchase plan. It provides issuance quantities, pricing, timetable, conditions, and other capital‐raising details. This is clearly an announcement of a share issue/capital change rather than a full financial report, earning release, or proxy statement. Therefore, it falls into the Share Issue/Capital Change category (SHA).
2026-04-15 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.